Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 1,124
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

1,124 results for “healthy” Back to intelligence hub

Search results

Page 34 of 47
  1. SHP643

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  2. SHP681

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  3. SHR2554 and Itraconazole

    Jian Li

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial
  4. SKY0402

    Pacira Ireland Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  5. SKY0402 300mg in healthy patients

    Pacira Ireland Limited

    Pain

    phase 1 small molecule completed

    1 trial
  6. SL TNX-102 2.4 mg at pH 3.5

    Tonix Pharmaceuticals Holding

    Healthy Adults

    phase 1 small molecule completed

    1 trial
  7. SL TNX-102 at 2.4 mg

    Tonix Pharmaceuticals Holding

    Healthy Adults

    phase 1 small molecule completed

    1 trial
  8. SLN124

    Silence Therapeutics plc

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  9. SNT-I-VAM-025

    Lacuna Pharma Pty Ltd

    Phase I study in healthy male volunteers. Intended indication: Duchenne muscular dystrophy and Becker muscular dystrophy

    phase 1 other active

    1 trial
  10. SNT-I-VAM-026

    Lacuna Pharma Pty Ltd

    Phase I study in healthy male volunteers. Intended indication: Duchenne muscular dystrophy and Becker muscular dystrophy

    phase 1 other active

    1 trial
  11. SNUCPT08_GCPGC

    Hospital Authority, Hong Kong

    Healthy

    phase 1 small molecule completed

    1 trial
  12. SOLOMON-I

    Lacuna Pharma Pty Ltd

    Healthy volunteers

    phase 1 other active

    1 trial
  13. SPD422

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  14. SPD503

    Takeda

    Healthy

    phase 1 small molecule completed

    2 trials
  15. SPN-817, Treatment B

    SUPERNUS PHARMACEUTICALS, INC.

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  16. SPR206

    CNS Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  17. SPR206

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  18. SPR720

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  19. SPR720

    Spero Therapeutics

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  20. SPR720 for SAD

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  21. SPR741

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  22. SPR994

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  23. SPY001-001

    Spyre Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial
  24. SPY002-072

    Spyre Therapeutics

    Healthy

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.